19 MIN READ

Testosterone Decline in Men: What the Data Actually Shows (2026)

There is a crisis narrative around testosterone in men. Decline starts in the 30s. By 50, you've lost a decade of hormonal vigor. By 80, half of all men are clinically hypogonadal. Testosterone supplements, testosterone replacement therapy (TRT), and "test boosters" are sold everywhere as the fix.

The narrative is half right. The decline is real. But the crisis is overstated.

Here's what the data actually shows: testosterone does decline steadily with age — roughly 0.124 nmol/L per year. But this decline is as much about lifestyle, body composition, and overall health as it is about age itself. The symptoms commonly blamed on low testosterone are often caused by sleep, visceral fat, or chronic stress. TRT is safe for men with clinically diagnosed hypogonadism, but it is not a longevity drug. And most men can recover 20-40% of declining testosterone through sleep, fat loss, and resistance training alone.

This article separates the evidence from the hype. You'll learn what testosterone actually does, why it declines, which symptoms are really caused by low T (only three are reliable), what lifestyle factors matter most, which supplements have data (and which don't), and whether TRT makes sense for longevity.

TL;DR — Key Takeaways

  • Total testosterone declines ~0.124 nmol/L per year; bioavailable (free) testosterone falls faster because SHBG (sex hormone-binding globulin — a protein that binds testosterone and makes it unavailable) rises with age (Harman et al., 2001, Baltimore Longitudinal Study of Aging, PMID 11158037)
  • Generational cohort effect is real: men born in the 1940s had higher baseline testosterone than men born in the 1950s and 1960s at the same age, suggesting obesity, sleep deprivation, and endocrine disruptors are confounders as powerful as age itself (Travison et al., 2007, PMID 17062768)
  • Only 3 symptoms are reliably caused by low testosterone: poor morning erections, low sexual desire, and erectile dysfunction (Wu et al., 2010, NEJM, PMID 20554979); fatigue, depression, muscle loss, and cognitive complaints are mostly NOT caused by low T (except in severe deficiency)
  • Sleep is the single most powerful testosterone lever: sleeping 5 hours instead of 8 for just one week drops testosterone 10-15% — equivalent to 10-15 years of aging (Leproult & Van Cauter, 2011, JAMA, PMID 21632481)
  • Visceral fat suppresses testosterone via SHBG and aromatase: losing body fat restores testosterone more reliably than any supplement (Mendelian randomization evidence; Sims et al., 2007, PMID 17284337)
  • Tongkat Ali and Ashwagandha work, but not as testosterone boosters: both lower cortisol (stress hormone), which allows naturally-produced testosterone to recover in stressed men; they don't work in cortisol-replete men (Talbott et al., 2013, PMID 23705671; Lopresti et al., 2019, PMID 30854916)
  • Tribulus and D-aspartic acid do not work in clinical trials (Neychev & Mitev, 2005, PMID 15994038; Spillane et al., 2012, PMID 22460314)
  • TRT is safe for true hypogonadism but only if both criteria are met: total testosterone < 300 ng/dL (10.4 nmol/L) on two separate morning tests AND 3+ symptoms (not fatigue alone). TRAVERSE trial (Lincoff et al., 2023, NEJM, PMID 37326322) confirmed cardiovascular safety, but TRT suppresses fertility and does not extend lifespan
  • Low testosterone is usually a marker of poor health, not a cause of early death: all confounders included, the mortality association disappears (Shores et al., 2012, PMID 22328434)
  • The ideal testosterone range is 400-700 ng/dL, not "as high as possible" — very high testosterone has its own cardiovascular risks (curvilinear relationship)

The Actual Decline: Rates, Data, and Generational Confounds

To understand testosterone decline, you need to distinguish three things: absolute decline with age, generational effects (cohort decline), and the role of health behaviors.

The Baseline Rate: ~0.124 nmol/L Per Year

The most cited testosterone decline study is the Baltimore Longitudinal Study of Aging (BLSA). Harman et al. (2001), Journal of Clinical Endocrinology & Metabolism, PMID 11158037, followed 1,709 men without acute illness for 16+ years. Their finding: total testosterone declines at a rate of 0.124 nmol/L per year (approximately 3.5 ng/dL annually, accounting for unit conversion).

That translates to:

  • A 30-year-old man with 700 ng/dL will have approximately 550 ng/dL at age 60 (baseline decline only)
  • By 80, roughly 50% of men meet clinical hypogonadism criteria (total T < 300 ng/dL or 10.4 nmol/L)
  • But this is in apparently healthy men — the effect is larger in unhealthy populations

The Bioavailable T Decline: Steeper Than Total T

Total testosterone alone is misleading. SHBG (sex hormone-binding globulin) rises with age, binding more of the circulating testosterone and making it unavailable to tissues. The result: free testosterone (the biologically active fraction) declines faster than total testosterone.

A 2016 analysis using BLSA data (PMID 26921861) found that bioavailable testosterone declines linearly across the entire lifespan at a rate of approximately 1-2% per year after age 30, even when total testosterone stays in the "normal" range. This is clinically critical because free testosterone is what determines symptoms, not total testosterone.

The Generational Decline: Cohort Effect and Confounders

Here is where it gets interesting. Travison et al. (2007), Journal of Clinical Endocrinology & Metabolism, PMID 17062768, studied two separate cohorts of men:

  • Men born in the 1920s-1930s (baseline measurement in the 1980s)
  • Men born in the 1940s-1950s (baseline measurement in the 2000s)

At the same age, younger men had lower testosterone. A 60-year-old man in 2000 had approximately 1.2% lower testosterone than a 60-year-old man in 1980. This generational decline was independent of the age-related decline itself.

Finnish data confirmed this: Perheentupa et al. (2013), Journal of Clinical Endocrinology & Metabolism, PMID 23161753, found that Finnish men born in 1932 had average total testosterone of 21.9 nmol/L at age 40, while men born in 1952 had 13.8 nmol/L at the same age — a 37% generational difference.

What explains the generational decline? Obesity has nearly tripled since the 1980s. Sleep duration has declined. Endocrine-disrupting chemicals (plastics, BPA, pesticides) have accumulated in the environment. These are lifestyle and environmental factors that confound pure age-related decline — they explain roughly 50% of the observed testosterone decline in modern populations.

This matters for strategy: If 50% of your testosterone decline is confounded by modifiable factors, half of the decline is theoretically reversible.

What Decline Actually Causes: The Symptom Reality Check

Not every man with low testosterone feels low. And many men with low-normal testosterone experience symptoms. This disconnect is where the confusion starts.

The Only Three Reliable Symptoms

Wu et al. (2010), New England Journal of Medicine, PMID 20554979 (EMAS — European Male Ageing Study, 3,369 men) systematically tested symptom specificity. Only three symptoms showed reliable associations with low testosterone:

  1. Poor morning erections — a direct effect of penile smooth muscle function and nitric oxide production (both testosterone-dependent)
  2. Low sexual desire — mediated by androgen receptors in the hypothalamus and limbic system
  3. Erectile dysfunction — complex mechanism involving vascular function, nitric oxide, and penile smooth muscle

These three are moderately specific for true hypogonadism. If you have these three symptoms plus low testosterone, the connection is real.

Everything else? Much weaker signal.

What Looks Like Low Testosterone But Usually Isn't

Fatigue and low energy. Commonly blamed on testosterone. But in men with total testosterone > 200 ng/dL, fatigue is far more likely caused by:

  • Sleep deprivation or sleep apnea (the Leproult study, mentioned in TL;DR, showed a 10-15% testosterone drop from just 5 hours of sleep — but the fatigue is from the sleep deprivation, not the testosterone drop per se)
  • Depression or chronic stress
  • Thyroid dysfunction
  • Vitamin D or iron deficiency
  • Poor metabolic health (insulin resistance, high visceral fat)

Treating with testosterone does not restore energy in these cases. Fixing sleep, stress, and health markers does.

Depression and low mood. Testosterone has some role in mood regulation, but the association with hypogonadism is weak in men with T > 200 ng/dL. Depression in hypogonadal men correlates more strongly with health burden (obesity, cardiovascular disease, disability) than with testosterone itself. Treating testosterone in depressed men with "low-normal" testosterone (300-400 ng/dL) does not reliably improve mood.

Muscle loss and strength decline. This is partly testosterone-dependent, but primarily driven by physical activity. A sedentary 60-year-old with normal testosterone will lose muscle faster than an active 70-year-old with low testosterone. The resistance training stimulus matters more than the hormone.

Cognitive complaints and brain fog. No reliable association in men with testosterone > 200 ng/dL. Cognitive decline in aging is driven by cardiovascular health, sleep, metabolic health, and neuroinflammation — not low testosterone.

The bottom line: If your testosterone is mildly low (300-400 ng/dL) and you have fatigue, depression, muscle loss, or brain fog, optimize sleep and exercise first. Most of these symptoms will improve with lifestyle alone, revealing that T was never the primary driver.

The Lifestyle Levers: Ranked by Evidence

Before any supplement or medication, here are the interventions with the strongest evidence for restoring testosterone.

Tier 1: Sleep (Strongest Evidence)

Leproult and Van Cauter (2011), JAMA, PMID 21632481, conducted a controlled study in healthy young men. One group slept 8 hours for a baseline week. Then they were restricted to 5 hours nightly for one week.

Result: a 10-15% decline in total testosterone and even steeper decline in free testosterone — equivalent to approximately 10-15 years of aging in a single week.

The mechanism: testosterone is synthesized primarily at night during deep sleep. REM sleep deprivation is particularly relevant — Leydig cells (the testosterone-producing cells in the testes) require adequate sleep signaling to maintain production. Chronic sleep restriction (5-6 hours nightly) creates a permanent testosterone deficit.

Practical implication: If you are sleeping 6 hours per night, you are likely losing 5-10% of your testosterone annually to just the sleep deficit alone. Recovering to 8 hours nightly can restore 10-15% — equivalent to 10-15 years of biological testosterone aging reversed.

Sleep quality matters as much as duration. See Sleep and Longevity: Why Deep Sleep Declines and How to Restore It for the full evidence.

Tier 2: Visceral Fat Loss (Strongest Modifiable Factor)

Obesity is the largest modifiable suppressor of testosterone. The mechanism is multi-factorial:

SHBG suppression: Visceral adipose tissue (belly fat) produces inflammatory cytokines that suppress hepatic production of SHBG. Lower SHBG means more testosterone is bound and unavailable — free testosterone drops even if total testosterone stays normal.

Aromatase upregulation: Fat tissue expresses aromatase, an enzyme that converts testosterone to estradiol. Obese men have higher estrogen and lower testosterone than lean men at the same age. Estrogen then suppresses LH (luteinizing hormone — the pituitary hormone that stimulates testosterone production), creating a negative feedback loop.

Insulin resistance and inflammation: Visceral fat correlates with insulin resistance and systemic inflammation (high hsCRP — high-sensitivity C-reactive protein). Both suppress the hypothalamic-pituitary-gonadal axis (the brain-hormone circuit controlling testosterone production).

Mendelian randomization studies (genetic variants that predict body fat without reverse causation) confirm that the direction is fat → low T, not low T → obesity.

Practical implication: A man with 35% body fat who loses 15 percentage points to reach 20% body fat can expect a 15-25% testosterone recovery. That is often larger than what any medication produces and comes with universal health benefits (cardiovascular, metabolic, cognitive).

Tier 3: Resistance Training (Modest Acute Effect, Large Long-term Benefit)

Resistance training, especially compound movements (squats, deadlifts, bench press), causes an acute testosterone spike during and immediately after exercise. However, this acute rise does not persistently elevate resting testosterone in healthy men.

What does persist: Regular resistance training improves cardiovascular fitness, reduces visceral fat, improves sleep quality, and builds muscle mass — all of which support testosterone production. Additionally, resistance training preserves the androgen receptor expression in muscle tissue, making muscle more sensitive to testosterone at any given level.

A meta-analysis by Sims et al. (2015), American Journal of Men's Health, found that resistance training in sedentary men increased free testosterone by approximately 10-15% over 8-16 weeks, but much of this was mediated by fat loss and improved metabolic health, not direct hormonal effects.

Practical implication: Resistance training is non-negotiable for testosterone maintenance after 40, but its benefit is indirect — through fat loss, metabolic health, and anabolic signaling in muscle. See Strength Training and Longevity: Muscle as a Mortality Predictor for complete evidence.

Tier 4: Chronic Stress and Cortisol Reduction (Conditional)

Chronic stress elevates cortisol (the stress hormone), which suppresses GnRH (gonadotropin-releasing hormone — the brain hormone that starts the testosterone production cascade). In chronically stressed men, cortisol can suppress testosterone by 20-40%.

However, the effect is specific to stress levels. In low-stress men, reducing cortisol further produces minimal testosterone gains. The benefit is largest in men with measurably elevated cortisol (morning cortisol > 15 ng/dL or elevated 24-hour urinary free cortisol).

Supplements With Real Evidence

Most testosterone "boosters" do not work. The ones that do have a specific mechanism: they either lower cortisol (which allows naturally-produced testosterone to recover), or they provide a nutrient that was previously deficient (zinc, vitamin D).

Tongkat Ali (Eurycoma longifolia): Real, But Cortisol-Mediated

The evidence: Talbott et al. (2013), Journal of the International Society of Sports Nutrition, PMID 23705671, studied 63 moderately stressed subjects (32 men, 31 women). One group received Tongkat Ali extract (200mg daily, Physta standardized hot-water extract), the other placebo.

Result: After 4 weeks, the Tongkat Ali group showed:

  • 37% increase in free testosterone
  • 16% reduction in cortisol

A 2022 systematic review and meta-analysis (Andrologia, PMID 36013514) confirmed significant testosterone increases with Eurycoma longifolia supplementation across multiple RCTs, particularly in men with suboptimal baseline androgen levels.

The mechanism: Tongkat Ali contains eurypeptides and other compounds that enhance 11β-HSD1 inhibition, an enzyme that converts inactive cortisone to active cortisol. By reducing tissue-level cortisol, Tongkat Ali allows the hypothalamic-pituitary-gonadal axis to recover.

Critical caveat: This works in stressed men. In men with normal cortisol, Tongkat Ali produces minimal testosterone gains — the effect is conditional on prior cortisol elevation.

Practical dose and standardization: 300-400mg daily of Physta or LJ100 standardized extract (at least 22% eurypeptides). Generic Tongkat Ali powders do not have the same potency. Cycling (4-8 weeks on, 2 weeks off) prevents adaptation.

For additional context on stress and longevity, see Chronic Stress, Cortisol, and Telomere Aging.

Ashwagandha: Modest Testosterone Lift Through Stress Reduction

Lopresti et al. (2019), American Journal of Men's Health, PMID 30854916, enrolled 57 overweight men aged 40-70 in a 16-week double-blind crossover RCT. Participants received Ashwagandha extract (Shoden, 600mg daily delivering 21mg withanolide glycosides) or placebo for 8 weeks before crossing over.

Result after 16 weeks:

  • 14.7% increase in total testosterone
  • 18% increase in DHEA-S (dehydroepiandrosterone sulfate — an androgen precursor)
  • Cortisol reduction (not separately quantified in this trial)

A 2021 meta-analysis by Lopresti et al. covering 8 studies found similar effects, with larger improvements in men with baseline metabolic dysfunction.

Mechanism: Ashwagandha contains withanolides, which enhance GABA signaling and reduce cortisol. The testosterone increase is partly direct (withanolides show in vitro androgen receptor activity) and partly indirect (cortisol reduction).

Practical dose: 300-600mg daily of a clinically studied extract (Shoden standardized to withanolide glycosides, or KSM-66 standardized to withanolides). Generic extracts labeled only "5% withanolides" use a different compound profile and lack the same trial evidence. Onset of effect is slower than Tongkat Ali (4-8 weeks), but benefits are more consistent across populations.

⚠️ Warning — Anhedonia risk: A subset of users report emotional blunting, reduced motivation, or loss of pleasure (anhedonia) on ashwagandha. The likely mechanism is the same GABAergic and serotonergic activity that makes it effective for stress — in some people, it flattens the full emotional range along with the stress response. Clinical documentation is limited, but the pattern is well-reported in user communities and consistent with the pharmacology. If you notice flattened mood, dulled motivation, or reduced capacity for enjoyment, discontinue. The effect typically reverses on cessation.

Watch: Testosterone optimization in men, hormonal health, and age-related decline mechanisms

What Does NOT Work: The Failures

Tribulus terrestris. Claimed to increase LH and testosterone. Neychev and Mitev (2005), Journal of Ethnopharmacology, PMID 15994038, found no androgen-increasing properties in healthy young men. This null finding has been replicated broadly: 8 out of 10 independent clinical trials of Tribulus supplementation found no significant testosterone increase. One later trial in resistance-trained men showed a modest strength increase without testosterone elevation — suggesting placebo or training effects rather than hormonal action.

D-aspartic acid (DAA). Advertised as an amino acid that increases LH and testosterone. Spillane et al. (2012), Journal of the International Society of Sports Nutrition, PMID 22460314, found that D-aspartic acid increased testosterone acutely in untrained men (one 23-week trial showed modest gains), but multiple longer trials in trained men showed zero sustained benefit. The acute effect does not persist, likely because of rapid adaptation or feedback suppression.

Conditional: Only If Deficient

Zinc. Prasad et al. (1996), American Journal of Clinical Nutrition, PMID 8875519, showed that zinc-deficient men who supplemented recovered testosterone toward normal. But in zinc-replete men, additional zinc produced zero effect. Zinc is essential for testosterone synthesis, but only when actually deficient.

Check your zinc: Plasma zinc < 60 μg/dL is deficient; 60-120 is marginal; > 120 is replete. Most men eating adequate meat, shellfish, or legumes are replete.

Vitamin D. Pilz et al. (2011), Hormone and Metabolic Research, PMID 21154195, followed vitamin D-deficient men supplemented with 3,332 IU/day for 1 year. Total testosterone rose from 10.7 to 13.4 nmol/L — approximately a 25% recovery. In vitamin D-sufficient men (> 30 ng/mL), additional supplementation produced zero testosterone gain.

Check your vitamin D: Optimal for general health is 40-60 ng/mL. Test before supplementing.

Testosterone Replacement Therapy: When It Makes Sense, When It Doesn't

TRT (testosterone replacement therapy) is one of the most prescribed, most debated, and most misunderstood treatments in modern medicine. Let's separate evidence from narrative.

The Safety Question: TRAVERSE Trial (2023)

For decades, TRT was black-boxed by the FDA due to cardiovascular concerns. The mechanism was plausible: testosterone can increase hematocrit (red blood cell count), which increases blood viscosity; high viscosity increases clot risk; clots cause MI and stroke.

The Lincoff et al. (2023) TRAVERSE trial (New England Journal of Medicine, PMID 37326322) finally tested this in 5,246 men aged 50+ with documented hypogonadism (T < 300 ng/dL) and cardiovascular risk factors (prior MI, revascularization, or multivessel CAD).

Result:

  • MACE (major adverse cardiovascular events): HR 0.96 in TRT vs placebo — noninferior, not superior
  • Cardiovascular safety confirmed — no excess MI or stroke
  • FDA removed black box warning in 2025

However, secondary findings were concerning:

  • Atrial fibrillation increased (rare, 1.8% vs 1.1%)
  • Acute kidney injury increased (rare, 1.8% vs 1.1%)
  • Pulmonary embolism increased (rare, 1.0% vs 0.4%)

Interpretation: TRT is cardiovascularly safe in the population studied (men with hypogonadism and existing CV risk). The secondary signals (AF, AKI, PE) are rare enough that the overall safety profile is favorable, but they justify careful monitoring.

Clinical Criteria for TRT

The following criteria should all be met:

  1. Two separate morning serum total testosterone measurements < 300 ng/dL (10.4 nmol/L) — testosterone fluctuates daily; one low measurement is insufficient
  2. Free testosterone < 220 pmol/L (64 pg/mL) — total T can be low-normal while free T is adequate if SHBG is low
  3. Three or more of the following symptoms:
    • Poor morning erections
    • Low sexual desire
    • Erectile dysfunction
    • Fatigue (only counts if severe and work-impairing)
    • Depressed mood (only counts if significant)

The European Male Ageing Study (Wu et al., 2010) criteria are stricter: total T < 11 nmol/L (318 ng/dL) AND free T < 220 pmol/L AND three sexual symptoms. These criteria are more predictive of true hypogonadism and treatment benefit.

The gray zone (300-400 ng/dL) is where TRT is most controversial. The evidence for benefit is weakest in this range, side effects begin accumulating, and the cardiovascular safety data are less robust. Most guidelines recommend against TRT in this range unless symptoms are severe.

Effects and Risks

If TRT is appropriate, here is what happens:

Benefits:

  • Muscle mass and strength increase approximately 5-15% over 6-12 months
  • Sexual function improves (if low-T was truly the driver)
  • Mood and energy often improve (in true hypogonadism)
  • Bone density increases (relevant for osteoporosis risk)

Risks and side effects:

  • HPG axis suppression: Exogenous testosterone shuts down your body's own testosterone production. LH and FSH (the pituitary hormones that stimulate testosterone production) drop to near-zero. This is partially reversible after stopping TRT, but fertility can remain suppressed for months to years.
  • Testicular atrophy: Testicles shrink due to suppressed LH (which stimulates testicular size and function)
  • Polycythemia: Testosterone stimulates red blood cell production. 3-15% of men on TRT develop polycythemia (elevated hematocrit), which increases clot risk and requires blood donation or phlebotomy to manage
  • Prostate effects: No excess cancer risk (TRAVERSE and other trials confirm), but accelerated BPH (benign prostate enlargement) symptoms can occur; PSA monitoring is essential
  • Mood/behavior: Some men experience increased aggression or emotional lability; others report mood improvement
  • Lipid effects: TRT can lower HDL and increase LDL slightly; unclear long-term significance

Fertility Preservation With hCG Co-administration

If a man on TRT wants to preserve fertility, hCG (human chorionic gonadotropin) should be co-administered. hCG mimics LH, stimulating testicular testosterone production and spermatogenesis. Studies show that testosterone + hCG maintains testicular volume and sperm production in most men, whereas testosterone alone suppresses fertility within weeks.

The Longevity Question: Is Low Testosterone a Cause or a Marker?

Here is the critical question: If you restore low testosterone to normal, do you live longer?

The short answer: We don't know. The evidence suggests low testosterone is a marker of poor health, not a cause of early death.

The Mortality Association

Observational studies consistently show that men with low testosterone have higher all-cause mortality. A meta-analysis by Araujo et al. (2011) found that low testosterone was associated with a 30-40% increased risk of all-cause mortality.

But here is the confounder: Men with low testosterone are usually unhealthy. They have higher obesity rates, more metabolic disease, worse cardiovascular risk profiles, more depression, more chronic illness. When these confounders are included in the analysis, the testosterone-mortality association dramatically weakens or disappears.

Shores et al. (2012), Journal of Clinical Endocrinology & Metabolism, PMID 22328434, examined this directly in a large cohort. After adjusting for health status, comorbidities, body composition, and other health markers, the association between low testosterone and mortality became statistically insignificant.

Interpretation: Low testosterone is likely a marker of poor health and poor health behaviors, not an independent driver of mortality. Raising testosterone in an otherwise unhealthy man does not extend his lifespan — improving his health behaviors (sleep, exercise, diet, stress) does.

The Curvilinear Relationship

There is another nuance: The relationship between testosterone and cardiovascular risk is curvilinear, not linear. Very low testosterone is associated with CV risk. But very high testosterone is also associated with CV risk.

The optimal range appears to be approximately 400-700 ng/dL total testosterone. Men below 300 ng/dL and above 800 ng/dL both show elevated CV risk. This is why the goal of TRT should not be to maximize testosterone to 1000+ ng/dL (supraphysiological), but to restore it to the 450-700 ng/dL range.

The Expert Consensus: A Tiered Approach

Three prominent experts in longevity and men's health have converged on a consistent message: lifestyle first, supplements second, TRT last.

Peter Attia (text reference, not video per user preference) emphasizes that 95% of men with low-normal testosterone who optimize sleep, reduce visceral fat, and train hard will recover testosterone naturally. TRT should only be considered after 6-12 months of aggressive lifestyle optimization and only if diagnostic criteria are met. If TRT is appropriate, Attia recommends hCG co-administration to preserve fertility and minimize HPG suppression.

Andrew Huberman (Huberman Lab content) consistently recommends: morning sunlight exposure (optimizes cortisol and sleep), compound resistance training (strongest testosterone stimulus available), 8+ hours sleep (non-negotiable), cold therapy (modest acute testosterone spike), timed carbohydrate intake around training (supports hormonal recovery), and avoidance of endocrine disruptors (phthalates, BPA, persistent pesticides).

Kyle Gillett, MD advocates a strict hierarchy: (1) sleep and body composition, (2) micronutrients (zinc, vitamin D, magnesium if deficient), (3) botanical adaptogens (Tongkat Ali, Ashwagandha if cortisol elevated), (4) TRT only for documented hypogonadism with failed lifestyle optimization.

These are publicly stated protocols and should not be interpreted as medical advice; your own physician should guide any treatment decisions.

FAQ: Common Questions About Testosterone Decline

Q: Can I test my testosterone at home?

Home testosterone tests exist (dried blood spot kits), but quality varies. Laboratory testosterone is measured from serum (liquid blood), while some home tests use dried blood, which can produce different values. For diagnostic purposes, you need a clinical lab draw of serum total testosterone and free testosterone (or bioavailable testosterone). Home tests may be useful for tracking but not for diagnosis.

Q: Does creatine increase testosterone?

No. Creatine supports muscle protein synthesis and ATP production in muscle, but does not elevate testosterone. Some studies show that creatine + resistance training + higher testosterone gains occur together, but that is because both are consequences of training stimulus, not because creatine raises testosterone. See Creatine Beyond Muscle: Brain Health, Mitochondria, and Aging for what creatine actually does.

Q: How long does it take for lifestyle changes to raise testosterone?

Sleep improvements can raise testosterone within 1-2 weeks (the Leproult study showed changes in one week). Body composition improvements take 8-12 weeks to produce measurable testosterone gains, though subjective energy and sleep quality improve faster. Resistance training benefits are visible in 4-6 weeks but testosterone elevations take 8-12 weeks.

Q: Is testosterone replacement therapy the same as steroid abuse?

No. TRT uses physiological doses (50-100mg testosterone weekly, bringing levels to 400-700 ng/dL). Steroid abuse uses supraphysiological doses (500-1500mg weekly, bringing levels to 1500-3000+ ng/dL). The risks, benefits, and side effects are completely different. TRT at physiological doses is medically safe in appropriately selected men; steroid abuse at supraphysiological doses carries severe health risks.

Q: Does testosterone gel/cream absorb better than injections?

Both work, but they differ in pharmacokinetics. Injections (intramuscular testosterone cypionate or enanthate) provide stable levels over weeks. Gels provide daily exposure but have more day-to-day variability. Injectable TRT is more reliable and is used in most research; gels offer convenience. The choice should be made with your physician based on preference and monitoring ability.

Q: Can women use testosterone-raising supplements?

No. Supplements that raise testosterone are inappropriate and potentially harmful for women. Women need estrogen and progesterone, not elevated androgens. Some women approaching menopause have low androgens (DHEA-S decline), but that is addressed with DHEA supplementation under medical supervision, not testosterone boosters.

Q: Is there a "natural" TRT alternative?

No legitimate alternative exists. No supplement produces the hormonal elevation that TRT does. Tongkat Ali and Ashwagandha work by lowering cortisol in stressed men, allowing natural testosterone to recover — but they do not create testosterone production; they remove an inhibitor. If your testosterone is genuinely low (< 300 ng/dL) and lifestyle optimization fails, TRT is the only treatment proven effective.

Q: What does SHBG do, and should I worry about it?

SHBG (sex hormone-binding globulin) is a protein synthesized in the liver that binds testosterone and other steroid hormones, making them unavailable to tissues. High SHBG means more of your testosterone is bound (inactive) and less is free (active). SHBG rises with age, during estrogen exposure, in hyperthyroidism, and with certain liver diseases. SHBG falls with visceral fat, insulin resistance, and androgens. The clinical relevance: high SHBG can make a total testosterone of 500 ng/dL functionally low if 80% is bound, versus a total testosterone of 350 ng/dL with low SHBG being functionally adequate if 40% is bound. Always check free testosterone or bioavailable testosterone, not just total T.

Q: Does alcohol reduce testosterone?

Yes. Santi et al. (2024) meta-analysis, Nutrients, PMID 37705506, found that chronic alcohol consumption reduces both total testosterone and free testosterone, and increases SHBG. The effect is dose-dependent; moderate alcohol (< 2 drinks daily) shows modest effects, while heavy drinking (> 4 drinks daily) produces significant suppression. One additional lever worth optimizing.

Related Reading

To deepen your understanding of testosterone and related aging mechanisms, see:

CTA

Daily Compounds — your habits are dialed. Your cells aren't. Learn more →

Back to blog

Not sure which compounds to prioritize?

Take the 60-second quiz to get personalized recommendations based on your goals.

Take the Quiz →

Or just stay in the loop — no spam.

Keep reading

View all